Zobrazeno 1 - 10
of 106
pro vyhledávání: '"G. J. Knight"'
Autor:
David K. Stevenson, G Bernaschek, Michael Hayde, John A. Widness, James E. Haddow, G J Knight
Publikováno v:
Acta Paediatrica. 88:327-331
The objective of this study was to examine the association of carboxyhemoglobin (COHb) and plasma cotinine levels among pregnant women who smoke cigarettes and their fetuses. Fifteen pregnant women who smoked and their fetuses undergoing cordocentesi
Publikováno v:
Journal of Medical Screening. 11:170-174
Objective: To further explore first and second trimester reference ranges for thyroid stimulating hormone (TSH) and examine within-person variability of TSH and thyroid peroxidase (TPO) antibody. Setting: Women coming for routine prenatal care in ear
Publikováno v:
Journal of Medical Screening. 8:2-7
Objective To compare the Down's syndrome screening performance of a simplified dimeric inhibin-A assay (Diagnostic Systems Laboratories (DSL)) with an assay whose clinical utility has been established (Serotec). Setting A case control set consisting
Autor:
John M. Opitz, Linda A Bradley, G.S. Tint, Mira Irons, G J Knight, Glenn E. Palomaki, Richard I. Kelley, James E. Haddow
Publikováno v:
American Journal of Medical Genetics. 82:355-358
Publikováno v:
Journal of Medical Screening. 5:115-119
Objectives To determine the second trimester Down's syndrome screening performance of maternal serum dimeric inhibin A, both alone and in combination with existing serum markers. Setting A case-control set of serum samples from patients with Down's s
Autor:
Barbara A. Chilmonczyk, James E. Haddow, Glenn E. Palomaki, Andrea Pulkkinen, G J Knight, Josephine Williams
Publikováno v:
American Journal of Public Health. 80:1205-1208
We collected information about household smoking habits from 518 mothers when they made their first well child visit with a 6 to 8-week old infant. A urine sample was also collected from the infant, the cotinine concentration measured, and the measur
Publikováno v:
Prenatal Diagnosis. 18:291-293
To investigate whether statistical parameters used in Down syndrome screening between 15 and 22 weeks of pregnancy can be used at 14 weeks, we assayed alpha-fetoprotein (AFP), unconjugated oestriol (uE3), total human chorionic gonadotrophin (hCG), fr
Publikováno v:
Clinical Chemistry. 40:562-564
Creatinine and specific gravity (relative density) measurements both allow differences in urine concentration to be taken into account in determining urine cotinine concentrations. In this study we demonstrate that the variance of urine cotinine meas
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome
Publikováno v:
Journal of medical screening. 9(1)
Objectives: To design a reliable model in the context of prenatal screening for assigning the risk in an individual pregnancy of Smith-Lemli-Opitz syndrome (SLOS) and assess its performance. Setting: A 2nd trimester screening programme for Down's syn